Home›Compare›MangoRx vs SnagRx

MangoRx vs SnagRx: Which Is Better?

Head-to-head comparison of MangoRx and SnagRx based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

MangoRx scores higher overall in our independent evaluation (58/100 vs 54.8/100), leading on trust & safety, experience, product range, reputation. SnagRx comes out ahead on value.

58

MangoRx is the Dallas-based men's health telehealth brand of Nasdaq-listed Mangoceuticals, selling compounded ED, hair-loss and oral semaglutide products alongside injectable and oral (Kyzatrex) testosterone.

Visit MangoRx
55
SnagRx
Below Average

SnagRx is a 2026 compounded-GLP-1 storefront run by Modern Metabolic Medicine, Inc., which also operates Embody and RodeoMeds. It sells semaglutide from $69/mo and tirzepatide from $119/mo on 12-month prepay.

Visit SnagRx

Score Breakdown

DimensionMangoRxSnagRx
Overall Score58/100 ✓54.8/100
Trust & Safety30%55/100 ✓50/100
Value25%62/10085/100 ✓
Experience20%58/100 ✓45/100
Product Range15%66/100 ✓40/100
Reputation10%45/100 ✓35/100

At a Glance

Founded20212026
HeadquartersDallas, TXWilmington, DE
Publicly tradedYes (MGRX)No
Treatment categories51
Treatments listed52
Starting price$50/mo$69/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryMangoRxSnagRx
Weight Loss / GLP-1$299
Slim (compounded oral semaglutide ODT)
$69–$99
Compounded Semaglutide

MangoRx

+Injectable TRT program priced at $99/month with doctor visits, lab work and medication included (per February 2026 company release and current site listing)
+Offers a branded FDA-approved oral testosterone option (Kyzatrex-based 'Prime') alongside compounded injectable TRT, which few small men's-health platforms carry
+Public-company SEC disclosures make ownership, pharmacy relationships and finances unusually visible for a brand this size
−Going-concern risk: $228,688 cash on hand at June 30, 2026 against a six-month net loss of $4.7M, per its Q2 2026 10-Q
−Compounded products are filled by Epiq Scripts, a pharmacy majority-owned (52%) by the CEO, a related-party arrangement
−Very small patient base: Q2 2026 revenue of $68,757, down 59% year over year, and only 18 Trustpilot reviews
Read the full MangoRx review →

SnagRx

+Among the lowest compounded GLP-1 prices we track: semaglutide $69–99/mo and tirzepatide $119–149/mo, flat across doses, no membership fee
+Names four dispensing pharmacies and its prescriber network (OpenLoop Health)
+Consult, supplies and 1–2 day temperature-controlled shipping included
−Multi-month plans are non-refundable in whole and in part; reviewers say the $69/mo headline was not clear as a $828 upfront charge
−Parent company's shared BBB profile (SnagRx, Embody, RodeoMeds) is rated C with 72 complaints; the common ownership is not disclosed on the storefronts
−Claims 125,000+ customers but has only a handful of Trustpilot reviews (3.1/5), citing 19-day fulfillment delays
Read the full SnagRx review →

MangoRx vs SnagRx — FAQ

Is MangoRx better than SnagRx?

▾

MangoRx scores higher overall in our independent evaluation (58/100 vs 54.8/100), leading on trust & safety, experience, product range, reputation. SnagRx comes out ahead on value.

Is MangoRx or SnagRx cheaper?

▾

MangoRx has the lower starting price (from $50/mo vs $69/mo for SnagRx). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do MangoRx and SnagRx both offer?

▾

Both platforms treat Weight Loss / GLP-1. MangoRx covers 5 treatment categories total and SnagRx covers 1.

Still deciding?

MangoRx alternativesSnagRx alternativesTake the Match Quiz